Results 261 to 270 of about 3,163,010 (367)
Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase [PDF]
, 1978 J Breton-Gorius +4 more
openalex +1 more source
Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives
American Journal of Hematology, EarlyView.ABSTRACT Myelofibrosis (MF) is a myeloproliferative neoplasm that is accompanied by driver JAK2, CALR, or MPL mutations in more than 90% of cases, leading to constitutive activation of the JAK–STAT pathway. MF is a multifaceted disease characterized by trilineage myeloid proliferation with prominent megakaryocyte atypia and bone marrow fibrosis, as ...
Giuseppe G. Loscocco, Paola Guglielmelli
wiley +1 more source
Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia [PDF]
, 1977 LW Dow +6 more
openalex +1 more source
American Journal of Hematology, EarlyView.ABSTRACT Allogeneic hematopoietic stem‐cell transplantation (HCT) remains the only potentially curative therapy for patients with myelodysplastic neoplasms (MDS) and myelofibrosis (MF) and is the standard care for eligible patients with higher‐risk disease. Despite significant advancements, both diseases pose unique challenges due to their clinical and
Nico Gagelmann, Nicolaus Kröger
wiley +1 more source
Revumenib for patients with acute leukemia: a new tool for differentiation therapy. [PDF]
HaematologicaSalman MY, Stein EM.
europepmc +1 more source
Clinical implications of aneuploid cyto genetic profiles in adult acute leukemia [PDF]
, 1974 José M. Trujillo +4 more
openalex +1 more source
Recent Developments and Evolving Therapeutic Strategies in KMT2A-Rearranged Acute Leukemia. [PDF]
Cancer MedYin L, Wan L, Zhang Y, Hua S, Shao X.
europepmc +1 more source